FindTrial
Sign In

The steady state pharmacokinetics (PK) of atazanavir boosted with ritonavir during pregnancy and postpartum in HIV-1 infected pregnant women

The steady state pharmacokinetics (PK) of atazanavir boosted with ritonavir during pregnancy and postpartum in HIV-1 infected pregnant women

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-004809-29-IT
Enrollment
Unknown
Registered
2007-09-12
Start date
2006-01-12
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV-1 infected pregnant women

Interventions

Trade Name: REYATAZ*60CPS 150MG Pharmaceutical Form: Capsule, hard Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 300- Trade Name: NORVIR*4FL 84CPS MOLLI 100MG Ph

Sponsors

AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026